Sign inJoin waitlistJoin the waitlist

Robert Grubb

Professor, Department of Urology · Medical University of South Carolina College of Medicine

Credentials: · · · ·

History

Medical University of South Carolina College of Medicine
Present

Clinical Center at the National Institutes of Health
2002–2005
Urology
Washington University/B-JH/SLCH Consortium
1998–2002
General Surgery
Washington University/B-JH/SLCH Consortium
1996–1998
Emory University School of Medicine
1992–1996
Davidson College
1988–1992
Neurological Surgery
Washington University/B-JH/SLCH Consortium
1966–1973

Research

Mortality results from a randomized prostate-cancer screening trial
New England Journal of Medicine · 2009 · 2,143 citations
Prostate cancer screening in the randomized Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial: mortality results after 13 years of follow-up
Journal of the National Cancer Institute · 2012 · 812 citations
Importance of hemodynamic factors in the prognosis of symptomatic carotid occlusion
JAMA · 1998 · First of 8 authors · 639 citations

Colin Derdeyn
32 papers
William Powers
30 papers
GA
Gerald Andriole
29 papers · 1 as a resident
Adam Kibel
19 papers
David Crawford
13 papers
Harold Adams
9 papers
BK
Barnett Kramer
8 papers
JC
Jonathan Coleman
8 papers · 4 as a fellow
Eric Kim
7 papers · 4 as a fellow
Ted Skolarus
7 papers · 5 as a resident
DC
David Carpenter
6 papers
KY
Kent Yundt
6 papers · 5 as a resident

Grants

Cerebral Hemodynamics and Ischemic Stroke
National Institute of Neurological Disorders and Stroke · R01
Contact PI · $1.9M · Washington University
1991–1997
Brain and Its Vasculature
National Institute of Neurological Disorders and Stroke · P50
Project lead · Washington University
Brain and Its Vasculature
National Institute of Neurological Disorders and Stroke · P01
Project lead · Washington University

Clinical trials

Feasibility Study of Prostate Tumor Localization for Focal Cryoablation of Prostate Carcinoma
Principal investigator · Terminated
Washington University School of Medicine
2009–2014
Testing the Addition of an Anti-Cancer Drug, Gemcitabine, to Usual Treatment (BCG Alone) in People Whose Non-Muscle Invasive Bladder Cancer (NMIBC) Came Back After Prior BCG Therapy
Site PI · Recruiting · Phase 3
Alliance for Clinical Trials in Oncology
2025–2028
Comparing the Outcome of Immunotherapy-Based Drug Combination Therapy With or Without Surgery to Remove the Kidney in Metastatic Kidney Cancer, the PROBE Trial
Site PI · Recruiting · Phase 3
SWOG Cancer Research Network
2021–2033